Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation

Transplantation

Volumn 67, Issue 1, 1999, Pages 38-45

  Meyer, Carole ^a,b   Wolf, Philippe ^a   Romain, Nathalie ^a   Ravanat, Catherine ^c   Roussi, Jacqueline ^d   Beller, Jean Paul ^a   Imbs, Pierre ^a   Chenard, Marie Pierre ^a   Fabre, Michel ^e   Kieny, Rene ^a   Bonneau, Michel ^f   Drouet, Ludovic ^d   Cazenave, Jean Pierre ^c   Soulillou, Jean Paul ^c   Azimzadeh, Agnes ^a  

^a Laboratoire de Chirurgie Experimentale   (France)

^b Fondation Transplantation   (France)

^c INSERM   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SURVIVAL TIME; SWINE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOLOGIC DISEASES; HEMOSTASIS; IMMUNOHISTOCHEMISTRY; IMMUNOSORBENT TECHNIQUES; KIDNEY; KIDNEY TRANSPLANTATION; MICROSCOPY, ELECTRON; PAPIO; POSTOPERATIVE COMPLICATIONS; SWINE; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0033556461     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00006     Document Type: Article

References (32)

1. Ye Y, Cooper DKC. Experimental xenotransplantation in non-human primates using distantly related donor species. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation: the transplantation of organs and tissues between species. Berlin Heidelberg: Springer-Verlag, 1991: 389.
2. Bach FH, Robson SC, Ferran C, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141: 5.
3. Cooper DKC. Depletion of natural antibodies in non-human primates: a step towards successful discordant xenografting in humans. Clin Transplant 1991; 6: 178.
4. Fischel RJ, Matas AJ, Platt JL, et al. Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival. J Heart Lung Transplant 1992; 11: 965.
5. Waterworth PD, Cozzi E, Tolan MJ, et al. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transplant Proc 1997; 29: 899.
6. Byrne G, McCurry KR, Martin MJ, Mcclellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63: 149.
7. Bach FH, Auchincloss H, Robson SC. Xenotransplantation. In: Bach FH, ed. Transplantation immunology. New York: John Wiley and Sons, 1995: 305.
8. Pareti FI, Mazzucato M, Bottini E, Manucci PM. Interaction of porcine von Willebrand factor with the platelet glycoprotein Ib and IIb/IIIa complex. Br J Haematol 1992; 82: 81.
9. Mazzucato M, Demarco L, Pradella P, Masotti A, Pareti FI. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 1996; 75: 655.
10. Hofer E, Stuhlmeier KM, Blakely ML, et al. Pathways of procoagulation in discordant xenografting. Transplant Proc 1994; 26: 1322.
11. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotransplantation. Nature Med 1995; 1: 869.
12. Candinas D, Lesnikoski B, Hancock WW, et al. Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts. Transplantation 1996; 62: 1.
13. Koyamada N, Miyatake T, Candinas D, et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 1996; 62: 1739.
14. Taniguchi S, Kitamura S, Kawachi K, Fukutomi M, Yoshida Y. Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasma-pheresis on cardiac xenograft survival. Transplant Proc 1994; 26: 969.
15. Takeshita K, Arakawa K, Okamoto M, et al. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection. Transplant Proc 1996; 28: 631.
16. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Int Med 1996; 239: 17.
17. Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb Haemost 1993; 70: 99.
18. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520.
19. Bowie EJW, Owen CA, Zollman PE, Thompson JH, Fass DN. Tests of hemostasis in swine: normal values and values in pigs affected with the von Willebrand's disease. Am J Vet Res 1973; 34: 1405.
20. Roussi J, Samama M, Vaiman M, et al. An experimental model for testing von Willebrand factor function: successful SLA-matched crossed bone marrow transplantations between normal and von Willebrand pigs. Exp Hematol 1996; 24: 585.
21. Meyer C, Azimzadeh A, Beller JP, et al. Extracorporeal immunoadsorption of xenoreactive natural antibodies in the pig/ rhesus model: comparison of three methods. Transplant Proc 1996; 28: 799.
22. Azimzadeh A, Meyer C, Watier H, et al. Removal of primate xenoreactive natural antibodies by extracorporeal perfusion of pig kidneys and livers. Transplant Immunol 1998; 6: 13.
23. Azimzadeh A, Wolf P, Thibaudeau K, Cinqualbre J, Soulillou JP, Anegon I. Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells. Transplantation 1997; 64: 1166.
24. Vanhove B, Bach FH. Human xenoreactive natural antibodies avidity and targets on porcine endothelial cells. Transplantation 1993; 56: 1251.
25. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996; 62: 303.
26. Vanhove B, de Martin RJ, Lipp J, Bach F. Human xenoreactive natural antibodies of the IgM isotype activate pig endothelial cells. Xeno 1994; 1: 17.
27. Sims PJ, Wiedmer T. The response of human platelets to activated components of the complement system. Immunol Today 1991; 12: 338.
28. Dalmasso AP, Vercellotti GM, Fischel JR, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
29. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289.
30. Coller BS, Anderson K, Weisman HF. New antiplatelet agents: platelet GPIIbIIIa antagonists. Thromb Haemost 1995; 874: 302.
31. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181: 21.
32. Mohri H, Yoshioka A, Zimmermann TS, Ruggeri ZM. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. J Biol Chem 1989; 264: 7361.